Summary & Overview
HCPCS Level II S5014: 5% Dextrose/0.45% Saline with KCl and MgSO4, 1500 ml
HCPCS Level II code S5014 denotes a compounded intravenous solution of 5% dextrose with 0.45% normal saline plus potassium chloride and magnesium sulfate in a 1500 ml container. This formulation is used for fluid resuscitation, maintenance fluids, and electrolyte repletion when both potassium and magnesium supplementation are required alongside dextrose-containing saline. Nationally, accurate coding for such compounded IV solutions affects billing clarity, payer coverage determinations, and inventory tracking for inpatient and outpatient infusion services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a compact overview of clinical context for the solution, common sites of service where the product is administered, and the types of benchmarks and policy considerations typically reviewed for HCPCS Level II supply codes. The publication summarizes reimbursement benchmarking, payer coverage patterns, and coding guidance considerations relevant to hospital and infusion center billing workflows.
The content emphasizes practical coding identification and national policy context without state-specific detail. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code S5014 represents 5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1500 ml. This code describes an intravenous electrolyte and dextrose solution prepared for infusion in a 1500 ml volume.
Service Type: Intravenous fluid/electrolyte therapy
Typical Site of Service: Inpatient hospital, outpatient infusion center, or other settings where IV fluids are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old hospitalized patient with prolonged vomiting and poor oral intake is receiving maintenance intravenous fluids formulated as S5014 (5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1500 ml) to correct dehydration, maintain electrolyte balance, and provide basal caloric support. The patient is admitted to a medical ward under internal medicine; orders are written by the attending physician and reviewed by nursing staff. Pharmacy compounds the premixed IV bag per the ordered concentration and delivers it to the floor. The registered nurse confirms patient identity, inspects the IV bag for integrity and expiration, spikes the bag, programs the infusion pump for the prescribed rate, and monitors intake, output, and serum electrolytes. Serum potassium and magnesium are rechecked within 4–24 hours after initiation and doses adjusted per lab results. If central venous access is present for other therapies, the same lumen may be used per facility policy; otherwise IV peripheral access is used. Changes in clinical status (arrhythmia, deterioration, or need for procedural sedation) prompt reassessment of fluid composition and rate.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when substantially greater resources are required to prepare or administer specialized IV fluid beyond typical practice (rare for premixed bags). |